This content is restricted.
Brief
"On 26/06/2025, the Therapeutic Goods Administration (TGA) issued an update regarding Product Information safety updates - June 2025. Recent safety-related Product Information changes have been made to various medicines, including Atomoxetine Sandoz, Avelumab, and Paracetamol-Aft, among others, adding new warnings for conditions such as serotonin syndrome, high anion gap metabolic acidosis, and tumour lysis syndrome, highlighting the importance of prescribers being aware of these changes."
Highlights content goes here...

RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested